Verseon is a drug discovery company addressing a problem that impacts everyone’s lives: the need for better medicines to keep us living healthier and longer. 

Verseon has developed a proprietary drug design platform which is more reliable, consistent, and cost-effective than existing drug discovery techniques.

The company is leveraging its target-agnostic platform to launch multiple drug discovery programs at a steady rate, resulting in a rapidly growing pipeline. Current drug programs include targets in cardiovascular diseases, oncology, and Alzheimer's.

Proprietary Platform

Consistently produces novel drug candidates that cannot be found by other existing methods

 

Pipeline

Diverse and rapidly growing portfolio of drug candidates across multiple major disease areas